$MRK Headlines Why the M&A outbreak hurts Big Pharma

New Post Public Reply Private Reply Replies (0) Message Board

Feb 8, 2015 at 10:54 AM

$MRK Headlines

Why the M&A outbreak hurts Big Pharma 10:30 a.m. Feb. 5, 2015 - David Weidner
Keurig Green Mountain burned by weak outlook, sales 6:35 p.m. Feb. 4, 2015 - Sue Chang
U.S. stocks end lower as ECB reject Greek bonds as collateral 4:33 p.m. Feb. 4, 2015 - Barbara Kollmeyer
Gilead to discount its pricey Sovaldi drug 1:55 p.m. Feb. 4, 2015 - Russ Britt
Careful what you wish for: Oil-price recovery may sting 8:28 a.m. Feb. 4, 2015 - Shawn Langlois
Merck sales fall amid headwinds 7:24 a.m. Feb. 4, 2015 - MarketWatch.com
Merck's stock falls 1.7% after earnings 7:16 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck sees 2015 sales of $38.3 bln to $39.8 bln 7:15 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck expects 2015 EPS $1.62-$1.91, adj. EPS of $3.32-$3.47 7:13 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck Q4 revenue falls 7% to $10.48 bln from $11.32 bln 7:12 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck reports Q4 EPS of $2.54, adj. EPS of $0.87 7:11 a.m. Feb. 4, 2015 - Silvia Ascarelli
What to look for in Merck earnings 11:41 a.m. Feb. 2, 2015 - Peter Loftus
Gasoline ‘tax cut’ in focus on energy, consumer-based earnings 6:13 a.m. Feb. 2, 2015 - Wallace Witkowski
Does Jersey’s lagging economy doom Christie’s bid? 8:31 a.m. Jan. 26, 2015 - Tim Mullaney
How you can cash in on the dollar’s coming decline 6:01 a.m. Jan. 22, 2015 - Michael Brush
Don’t look for pricey hepatitis drugs to come down 2:32 p.m. Jan. 13, 2015 - Russ Britt
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com

In Perspective: The Ridiculously Large Market Caps Of America's 20 Most Valuable Companies 21 min ago - Seeking Alpha
Week In Review: WuXi NextCode Leads $15 Million Financing In Claritas Genomics 4:46 a.m. Today - Seeking Alpha
AbbVie: Big Pharma at a Discount Price 4:24 a.m. Feb. 7, 2015 - Barrons.com
Gilead’s Dividend Debut; GM Relents 9:38 p.m. Feb. 6, 2015 - Barrons.com
Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More 4:00 p.m. Feb. 6, 2015 - Seeking Alpha
Dow 30 Stock Roundup: Disney, Exxon Beat, United Technologies Raises Dividend - Analyst Blog 2:15 p.m. Feb. 6, 2015 - Zacks.com
Gabelli's Q4 Picks Include Acquisition Targets 9:44 a.m. Feb. 6, 2015 - GuruFocus.com
Merck prices debt offering 7:04 a.m. Feb. 6, 2015 - Seeking Alpha
Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx 6:05 a.m. Feb. 6, 2015 - TheStreet.com
U.S. Stocks Post Big Rebound This Week, Still Best Investment 3:56 p.m. Feb. 5, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Lower 2:00 p.m. Feb. 5, 2015 - TheStreet.com
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary 11:00 a.m. Feb. 5, 2015 - Zacks.com
Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015 10:35 a.m. Feb. 5, 2015 - GuruFocus.com
The Reasons That Make Pfizer A Worthy Hold. 10:19 a.m. Feb. 5, 2015 - GuruFocus.com
Company News for February 05, 2015 - Corporate Summary 10:10 a.m. Feb. 5, 2015 - Zacks.com
Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines 9:31 a.m. Feb. 5, 2015 - 247WallSt.com
Mixed Signals, Extreme Volatility Plague Market 8:04 p.m. Feb. 4, 2015 - InvestorPlace.com
Stocks Falter After ECB Move 4:52 p.m. Feb. 4, 2015 - The Wall Street Journal Interactive Edition
Merck Sales Fall on Stronger Dollar, Patent Expirations 2:21 p.m. Feb. 4, 2015 - The Wall Street Journal Interactive Edition
HCV Stocks Struggle As Gilead, Merck Face Headwinds 11:12 a.m. Feb. 4, 2015 - Investors Business Daily

Fitch Rates Merck's Debt Offering 'A+'; Outlook Negative 1:07 p.m. Feb. 6, 2015 - BusinessWire - BZX
Merck Prices $8.0 Billion Debt Offering 7:37 p.m. Feb. 5, 2015 - BusinessWire - BZX
World Membrane Separation Technologies Industry, Global Industry Analysts 2:28 p.m. Feb. 5, 2015 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany 2:32 p.m. Feb. 3, 2015 - PR Newswire - PRF
Merck’s Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States 8:00 a.m. Feb. 3, 2015 - BusinessWire - BZX
Merck's Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States 8:00 a.m. Feb. 3, 2015 - PR Newswire - PRF
Technical Commentary on Pharma Stocks -- Merck, AbbVie, Bristol-Myers Squibb, Shire, and Mallinckrodt 8:45 a.m. Jan. 30, 2015 - PR Newswire - PRF
Hortonworks Establishes Data Governance Initiative 9:00 a.m. Jan. 28, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster 11:25 a.m. Jan. 27, 2015 - BusinessWire - BZX
TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster 10:00 a.m. Jan. 27, 2015 - BusinessWire - BZX
Euclises Announces Appointment of Bobby Sandage as New CEO 8:00 a.m. Jan. 27, 2015 - BusinessWire - BZX
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 12:33 p.m. Jan. 26, 2015 - PR Newswire - PRF
Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic SIVEXTRO® (tedizolid phosphate) 8:30 a.m. Jan. 26, 2015 - BusinessWire - BZX
Merck, on Behalf of its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Announces Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes due 2018 and 1.875% Convertible Senior Notes due 2020 3:29 p.m. Jan. 22, 2015 - BusinessWire - BZX
Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors 8:01 a.m. Jan. 22, 2015 - BusinessWire - BZX
Merck Completes Tender Offer to Acquire Cubist 8:03 a.m. Jan. 21, 2015 - BusinessWire - BZX
Dana Holding Set to Join the S&P MidCap 400 5:45 p.m. Jan. 20, 2015 - PR Newswire - PRF
Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024 10:36 a.m. Jan. 15, 2015 - PR Newswire - PRF
Insider Trading Alerts for Google, Oasis Petroleum, Best Buy, Twitter, Merck, and First Niagara Financial Group 8:45 a.m. Jan. 15, 2015 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Haier Dives into AI-Powered Smart Homes at IFA 2026

A Bold Step into the Future of Smart Homes Hold onto your hats, folks! Haier is making waves at IFA 2026, showing off smart home tech that's not just buzzing with AI but adapting right before our eyes. 'Home of Intelligent Possibilities' isn't just a catchy phrase—it's Haier promising us homes that think for themselves. From laundry to cooking, they’re tweaking those...

Postal Service Defends New Rule Amid Speculation

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

CHiQ Secures AI Award, Elevates Smart Home Living

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Virterion Surges Ahead in VPS Racing With Reliable Hosting

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Dr. Rashedi Reveals Laughing Gas Safety for Kids

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Actinium Pharma Unveils Plans at Key Investor Conference

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

GreenCore AI Agents Shatter Monthly Record in Ops Surge

Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....

Iwa Robotics Unveils Autonomous Drone Wildfire Fleet

A Sky Full of Drones: A New Era for Wildfire Management Iwa Robotics is flipping the script on how we handle urban wildfires by rolling out a trio of drones straight out of an action movie: HAWK, CANARY, and PELICAN. These aren't just your run-of-the-mill flying machines. They're the latest tech-packed companions for our brave firefighters on the ground, designed...